GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition

Prostate cell proliferation, driven by testosterone, is a major characteristic of benign prostatic hyperplasia (BPH). GV1001, a human telomerase reverse transcriptase catalytic subunit, is an injectable formulation used as a cancer vaccine. It functions as a cell penetrating peptide to regulate cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yejin, Lee, Dahae, Jo, Hyejung, Go, Cheolhyeon, Yang, Jongwon, Kang, Dongmin, Kang, Jae Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906190/
https://www.ncbi.nlm.nih.gov/pubmed/33539321
http://dx.doi.org/10.18632/aging.202242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906190/
https://www.ncbi.nlm.nih.gov/pubmed/33539321
http://dx.doi.org/10.18632/aging.202242

Ejemplares similares